HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 83 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2022. The put-call ratio across all filers is 29.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $281,000 | -32.5% | 31,758 | -3.6% | 0.00% | 0.0% |
Q2 2022 | $416,000 | +37.7% | 32,949 | +106.6% | 0.00% | 0.0% |
Q1 2022 | $302,000 | -42.6% | 15,949 | +6.4% | 0.00% | 0.0% |
Q4 2021 | $526,000 | -2.2% | 14,988 | +2.0% | 0.00% | 0.0% |
Q3 2021 | $538,000 | +1.5% | 14,688 | +8.9% | 0.00% | 0.0% |
Q2 2021 | $530,000 | +55.4% | 13,488 | +11.6% | 0.00% | 0.0% |
Q1 2021 | $341,000 | -8.1% | 12,088 | +4.4% | 0.00% | 0.0% |
Q4 2020 | $371,000 | -10.4% | 11,574 | -9.6% | 0.00% | 0.0% |
Q3 2020 | $414,000 | -35.0% | 12,810 | -44.5% | 0.00% | -50.0% |
Q2 2020 | $637,000 | +37.3% | 23,084 | -11.2% | 0.00% | +100.0% |
Q1 2020 | $464,000 | +45.0% | 25,984 | +103.7% | 0.00% | 0.0% |
Q4 2019 | $320,000 | -43.0% | 12,758 | -59.4% | 0.00% | 0.0% |
Q3 2019 | $561,000 | -50.6% | 31,458 | -39.1% | 0.00% | -66.7% |
Q2 2019 | $1,136,000 | -18.6% | 51,639 | +13.1% | 0.00% | -25.0% |
Q1 2019 | $1,396,000 | -34.9% | 45,639 | -50.9% | 0.00% | -33.3% |
Q4 2018 | $2,145,000 | – | 92,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zeal Asset Management Ltd | 2,684,118 | $84,523,000 | 16.48% |
Cederberg Capital Ltd | 3,400,000 | $108,868,000 | 2.00% |
Capital International Sarl | 570,500 | $18,267,000 | 1.91% |
AIA Group Ltd | 437,118 | $14,971,000 | 1.72% |
Capital International, Inc./CA/ | 4,711,405 | $150,859,000 | 1.40% |
M&G INVESTMENT MANAGEMENT LTD | 3,096,345 | $99,083,000 | 0.62% |
Bellevue Group AG | 947,674 | $30,345,000 | 0.35% |
Sands Capital Management | 7,051,916 | $225,802,000 | 0.22% |
E Fund Management (Hong Kong) Co., Ltd. | 18,836 | $603,000 | 0.21% |
Hudson Bay Capital Management LP | 1,031,212 | $33,020,000 | 0.18% |